KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 1 filers reported holding KRONOS BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 4.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,570 | -24.4% | 78,131 | 0.0% | 0.03% | +29.2% |
| Q2 2023 | $134,385 | +17.8% | 78,131 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $114,071 | -9.9% | 78,131 | 0.0% | 0.02% | -11.1% |
| Q4 2022 | $126,572 | -51.7% | 78,131 | 0.0% | 0.03% | -55.7% |
| Q3 2022 | $262,000 | -7.7% | 78,131 | 0.0% | 0.06% | -19.7% |
| Q2 2022 | $284,000 | -49.7% | 78,131 | 0.0% | 0.08% | -46.5% |
| Q1 2022 | $565,000 | -46.8% | 78,131 | 0.0% | 0.14% | -31.1% |
| Q4 2021 | $1,062,000 | -35.2% | 78,131 | 0.0% | 0.21% | -19.8% |
| Q3 2021 | $1,638,000 | -12.5% | 78,131 | 0.0% | 0.26% | +11.3% |
| Q2 2021 | $1,871,000 | -61.5% | 78,131 | -53.0% | 0.23% | -74.2% |
| Q1 2021 | $4,866,000 | -2.0% | 166,250 | 0.0% | 0.90% | +79.8% |
| Q4 2020 | $4,966,000 | – | 166,250 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
| Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
| Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
| COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
| Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
| Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
| Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
| Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
| Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |